These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 34369535)

  • 21. 4-Azidobenzyl ferrocenylcarbamate as an anticancer prodrug activated under reductive conditions.
    Kinski E; Marzenell P; Hofer W; Hagen H; Raskatov JA; Knaup KX; Zolnhofer EM; Meyer K; Mokhir A
    J Inorg Biochem; 2016 Jul; 160():218-24. PubMed ID: 26970945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction-Responsive Chemo-Capsule-Based Prodrug Nanogel for Synergistic Treatment of Tumor Chemotherapy.
    Lu Y; Jia D; Ma X; Liang M; Hou S; Qiu W; Gao Y; Xue P; Kang Y; Xu Z
    ACS Appl Mater Interfaces; 2021 Feb; 13(7):8940-8951. PubMed ID: 33565847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Manganese-deposited iron oxide promotes tumor-responsive ferroptosis that synergizes the apoptosis of cisplatin.
    Cheng J; Zhu Y; Xing X; Xiao J; Chen H; Zhang H; Wang D; Zhang Y; Zhang G; Wu Z; Liu Y
    Theranostics; 2021; 11(11):5418-5429. PubMed ID: 33859755
    [No Abstract]   [Full Text] [Related]  

  • 24. A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy.
    Chen Y; Yao Z; Liu P; Hu Q; Huang Y; Ping L; Zhang F; Tang H; Wan T; Ping Y; Li B
    Acta Biomater; 2023 Mar; 159():275-288. PubMed ID: 36709836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer.
    Wang K; Yang B; Ye H; Zhang X; Song H; Wang X; Li N; Wei L; Wang Y; Zhang H; Kan Q; He Z; Wang D; Sun J
    ACS Appl Mater Interfaces; 2019 May; 11(21):18914-18922. PubMed ID: 31055911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-Assembly Dual-Responsive NO Donor Nanoparticles for Effective Cancer Therapy.
    Gu G; Chen C; Zhang S; Yin B; Wang J
    ACS Appl Mater Interfaces; 2021 Nov; 13(43):50682-50694. PubMed ID: 34668695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer.
    Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J
    Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Codelivery of CPT and siPHB1 with GSH/ROS Dual-Responsive Hybrid Nanoparticles Based on a [12]aneN
    Liang YX; Sun XY; Xu DZ; Gao YN; Tang Q; Lu ZL; Liu Y
    ACS Appl Bio Mater; 2024 May; 7(5):3202-3214. PubMed ID: 38651918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glioblastoma Therapy Using Codelivery of Cisplatin and Glutathione Peroxidase Targeting siRNA from Iron Oxide Nanoparticles.
    Zhang Y; Fu X; Jia J; Wikerholmen T; Xi K; Kong Y; Wang J; Chen H; Ma Y; Li Z; Wang C; Qi Q; Thorsen F; Wang J; Cui J; Li X; Ni S
    ACS Appl Mater Interfaces; 2020 Sep; 12(39):43408-43421. PubMed ID: 32885649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiotherapy-mediated redox homeostasis-controllable nanomedicine for enhanced ferroptosis sensitivity in tumor therapy.
    Lin Y; Chen X; Yu C; Xu G; Nie X; Cheng Y; Luan Y; Song Q
    Acta Biomater; 2023 Mar; 159():300-311. PubMed ID: 36642338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binary Prodrug of Dichloroacetic Acid and Doxorubicin with Enhanced Anticancer Activity.
    Sharma A; Chun J; Ji MS; Lee S; Kang C; Kim JS
    ACS Appl Bio Mater; 2021 Mar; 4(3):2026-2032. PubMed ID: 35014328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Light-Responsive Pt(IV) Prodrugs with Controlled Photoactivation and Low Dark Toxicity.
    Spector D; Bubley A; Zharova A; Bykusov V; Skvortsov D; Ipatova D; Erofeev A; Gorelkin P; Vaneev A; Mazur D; Nikitina V; Melnikov M; Pergushov V; Bunin D; Kuzmin V; Kostyukov A; Egorov A; Beloglazkina E; Akasov R; Krasnovskaya O
    ACS Appl Bio Mater; 2024 May; 7(5):3431-3440. PubMed ID: 38697834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A General Strategy for Macrotheranostic Prodrug Activation: Synergy between the Acidic Tumor Microenvironment and Bioorthogonal Chemistry.
    Dong Y; Tu Y; Wang K; Xu C; Yuan Y; Wang J
    Angew Chem Int Ed Engl; 2020 Apr; 59(18):7168-7172. PubMed ID: 32003112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticancer Prodrug Capable of Mitochondria-Targeting, Light-Triggered Release, and Fluorescence Monitoring.
    Jung YL; Yang YJ; Shil A; Sarkar S; Ahn KH
    ACS Appl Bio Mater; 2024 Jun; 7(6):3991-3996. PubMed ID: 38835291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spatiotemporal Concurrent Liberation of Cytotoxins from Dual-Prodrug Nanomedicine for Synergistic Antitumor Therapy.
    Zhang L; Qian M; Cui H; Zeng S; Wang J; Chen Q
    ACS Appl Mater Interfaces; 2021 Feb; 13(5):6053-6068. PubMed ID: 33525873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A polyprodrug-based nanoplatform for cisplatin prodrug delivery and combination cancer therapy.
    Lin C; Tao Y; Saw PE; Cao M; Huang H; Xu X
    Chem Commun (Camb); 2019 Nov; 55(93):13987-13990. PubMed ID: 31687673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Light-Triggered Transformable Ferrous Ion Delivery System for Photothermal Primed Chemodynamic Therapy.
    He T; Yuan Y; Jiang C; Blum NT; He J; Huang P; Lin J
    Angew Chem Int Ed Engl; 2021 Mar; 60(11):6047-6054. PubMed ID: 33295682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ferrous-Supply-Regeneration Nanoengineering for Cancer-Cell-Specific Ferroptosis in Combination with Imaging-Guided Photodynamic Therapy.
    Liu T; Liu W; Zhang M; Yu W; Gao F; Li C; Wang SB; Feng J; Zhang XZ
    ACS Nano; 2018 Dec; 12(12):12181-12192. PubMed ID: 30458111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-Specific Multiple Stimuli-Activated Dendrimeric Nanoassemblies with Metabolic Blockade Surmount Chemotherapy Resistance.
    Li Y; Xu X; Zhang X; Li Y; Zhang Z; Gu Z
    ACS Nano; 2017 Jan; 11(1):416-429. PubMed ID: 28005335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutathione-responsive prodrug conjugates for image-guided combination in cancer therapy.
    Ye YX; Wu SY; Chen XY; Yu YW; Zeng SM; Wang ZC; Jiao QC; Zhu HL
    Eur J Med Chem; 2021 Dec; 225():113746. PubMed ID: 34388382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.